Press Releases

Acne Scar Treatment Market Size, Shares, Segmentation, Analysis, Competition, Applications & Challenges To 2022-2030

Share This Article

COVID-19 Stress Exacerbates Acne Problems

Unprecedented events caused by the COVID-19 pandemic have led to stressful environments, resulting in acne for both women and men. Stress related to coronavirus has worsen breakouts in individuals. Companies in the acne scar treatment market are capitalizing on this situation to increase the availability of topical treatments and in-office procedures.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111596

The ongoing stress with regular mask wear has led to acne problems in individuals. Hence, companies in the acne scar treatment market such as the Laser & Skin Surgery Center of New York is encouraging individuals to opt for laser treatment and photodynamic therapy that targets the acne-causing bacteria. In order to keep economies running, clinicians and dermatologists are customizing treatments for individuals for optimum outcome.

Lack of Insurance Cover for Laser Carbon Peels to Influence Treatment Preference

Laser carbon peels help to deeply exfoliate the skin and stimulate collagen production. Stakeholders in the acne scar treatment market are unlocking growth opportunities with this treatment, which is gaining popularity as a painless procedure to treat acne, acne scarring, and pigmentation. However, it has been found that laser carbon peels might not be covered in insurance, since it is part of a cosmetic procedure. Hence, it is advised that individuals undergo treatment from experienced doctors or licensed aestheticians to gain desired outcomes and avail value for money.

High precautions in cases of extra sensitive skin are likely to influence the preference for laser carbon peels, as dermatologists might suggest skipping the heating step.

Topical, Oral Medications Help Establish Stable Revenue Streams

Dermabrasion, derma filler injections, topical, and oral medications are helping to expand revenue streams for companies in the acne scar treatment market. This explains why the market is expected to cross US$ 10.8 Bn by the end of 2031. As such, oral medications such as Absorica and topical medications including Epiduo Forte and Atralin are gaining increased popularity.

Topical retinoids are becoming increasingly commonplace for the treatment of acne scarring and dark spots. Pharmaceutical companies in the acne scar treatment market are increasing their production capabilities of topical medications to help individuals get rid of scarring and discoloration. Over-the-counter creams, washes, and gels containing benzoyl peroxide or salicylic acid are being formulated to treat mild acne scars.

View full report@ https://qyresearchmedical.com/report/acne-scar-treatment-market-product-topical-medications-and-in-office-procedures-and-end-user-hospitals-clinics-and-retail-pharmacies-ecommerce-global-industry-analysis-size-share-growth-trends-and-fore-2021-2030/111596

Risk-free Approach, Cost Efficiency of Microneedling Catches Attention of Individuals

Microneedling is emerging as a breakthrough innovation in the acne scar treatment market. The JJ Ellie Derma roller is being publicized for specialized home skincare and microneedling, which is a cost-efficient and effective way to reduce scarring. The collagen-inducing effect of microneedling has shown efficacious outcomes for reducing acne scars. An increasing number of individuals is seen gravitating toward this relatively risk-free treatment that demonstrates short recovery time for patients and individuals.

Companies in the acne scar treatment market are creating awareness about the cost efficiency of microneedling for the management of post-acne scars. The documented evidence of this treatment of social media is creating incremental opportunities for skincare companies.

Inaccuracy in ECCA Gives Rise to 3D Imaging Technique

Key drivers such as 3D (3 dimensional) imaging technique for measuring the severity of atrophic acne scars is benefitting growth for the global acne scar treatment market. There is a dire need to upgrade clinical tools dermatologists use to assess the severity of acne scars. Dermatologist Hyemin Pomerantz, M.D., is gaining recognition for presenting her topic about 3D imaging technique at the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting, which helps to accurately measure the severity of acne scars.

Since existing measuring and grading tools such as the ECCA and the Global Aesthetic Improvement Scale lack objectivity, companies in the acne scar treatment market are increasing their R&D for enabling 3D morphology of acne scars.

Analysts’ Viewpoint

Extreme hair fall and acne resulting from COVID-19 stress have created lucrative opportunities for home skincare medications. Laser carbon peels are gaining increased popularity among individuals with oily skin, enlarged pores, and acne. However, these chemical peels lack permanent solutions to acne and acne scarring. Hence, companies in the acne scar treatment market should increase awareness about repeated treatment of laser carbon peels with the help of experienced doctors and licensed aestheticians. Oral medications including Isotretinoin (Absorica) are being publicized for targeting oil production and stimulating cell turnover. Topical antibiotics are showing efficacious outcomes in reducing breakouts, whereas oral medications containing anti-androgen agents and salicylic acid help reduce the amount of sebum (oil) that the skin produces.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111596/2900

Acne Scar Treatment Market: Overview

The global acne scar treatment market was valued at US$ 6 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Growth of the global acne scar treatment market can be attributed to rise in awareness about personal care, surge in adoption of eCommerce as a branding and marketing platform, increase in appearance consciousness, and rise in awareness among individuals about scar treatment.

Presence of key players with technologically advanced products and strong geographic presence are anticipated to propel the global acne scar treatment market. Key industry developments, including partnerships, mergers & acquisitions, and collaborations are expected to fuel the growth of the global acne scar treatment market.

According to the U.S.-based National Institute of Aging and American Academy of Plastic Surgeons, a significant percentage of the population of the U.S., primarily aged between 18 and 30, avails advanced skin, scar, and dermatology services. This creates opportunities for product manufacturers.

Companies such as Merz, Inc., Sonoma Pharmaceutical, Inc., and CCA Industries, Inc. adopt various eCommerce marketing techniques to sell their products, especially topical products. eCommerce companies provide topical products at discounted rate either through a coupon or product bundling options. This strategy has increased consistent purchase and usage of scar treatment products by consumers. This, in turn, helps companies expand their market presence across the world.

Increase in the number of product launches and collaborations among players are likely to boost the global acne scar treatment market

Acne Scar Treatment Market: Segmentation

The global acne scar treatment market has been segmented based on treatment, end user, and region

In terms of treatment, the global acne scar treatment market has been bifurcated into topical medications and in-office procedures. The topical medications segment has been split into alpha hydroxyacids (AHAs), retinoids, salicylic acid, and others. The in-office procedures segment has been segregated into dermabrasion, chemical peels, laser resurfacing, fillers, and microneedling. The topical medications segment dominated the global acne scar treatment market, owing to increase in awareness and easy availability of topical products over-the-counter.

Based on end user, the global acne scar treatment market has been classified into hospitals, clinics, and retail pharmacies/eCommerce. The hospitals segment accounted for a significant share of the market in 2020. Rise in demand for personal care & healthcare and presence of a large number of players are likely to drive the segment. Increase in appearance consciousness and health awareness are projected to accelerate the growth of the segment during the forecast period.

Acne Scar Treatment Market: Regional Segmentation

In terms of region, the global acne scar treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America is projected to be a highly attractive market from 2021 to 2031. Increase in the geriatric population has led to rise in the number of patients visiting hospitals & clinics. Moreover, advanced technologies and consumption of topical medications are anticipated to drive the market in North America during the forecast period.

The acne scar treatment market in Asia Pacific is expected to be driven by increase in awareness among prospective patients, particularly regarding aesthetic correction procedures. Growth of the market in the region can be attributed to rise in awareness about aesthetic treatment procedures and increase in affordability of these procedures. The market in Japan is propelled by increase in geriatric population, product innovation, and development of combination treatment options.

Acne Scar Treatment Market: Major Players

Key players operating in the global acne scar treatment market include

  • Merz Pharma GmbH & Co. KGaA
  • Bausch Health Companies, Inc.
  • Sonoma Pharmaceuticals, Inc.
  • Enaltus, LLC
  • Revitol Corporation, Inc.
  • Scarguard Labs LLC
  • CCA Industries, Inc.
  • Johnson & Johnson
  • Smith & Nephew plc.

These players focus on adopting various strategies to expand product offerings and to strengthen geographic presence across the globe. Technological advancements, mergers & acquisitions, expansion of product portfolio, and rise in research & development are strategies adopted by companies to expand market presence.

Key Questions Answered in Acne Scar Treatment Market Report

  • What are the sales/revenue generated by acne scar treatment manufacturers across all regions during the forecast period?
  • What are the key trends in the global acne scar treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will generate the highest revenue globally in 2031, and which segment will expand at the highest CAGR during the forecast period?
  • What will be the market ranking of different companies operating in the global market in 2020?

Acne Scar Treatment Market – Segmentation

Type

  • Topical Medications
  • Alpha Hydroxyacids (AHAs)
  • Retinoids
  • Salicylic Acid
  • Others
  • In-office Procedures
  • Dermabrasion
  • Chemical Peels
  • Laser Resurfacing
  • Fillers
  • Microneedling

End User

  • Hospitals
  • Clinics
  • Retail Pharmacies/eCommerce

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Acne Scar Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Acne Scar Treatment Market Analysis and Forecast, 2017–2031

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Regulatory Scenario by Region/globally

5.2. Key Mergers & Acquisitions

5.3. Pipeline Analysis

5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Acne Scar Treatment Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Acne Scar Treatment Market Value (US$ Bn) Forecast, by Product, 2017–2031

6.3.1. Topical Medications

6.3.1.1. Alpha Hydroxyacids (AHAs)

6.3.1.2. Retinoids

6.3.1.3. Salicylic Acid

6.3.1.4. Others

6.3.2. In-office Procedures

6.3.2.1. Dermabrasion

6.3.2.2. Chemical Peels

6.3.2.3. Laser Resurfacing

6.3.2.4. Fillers

6.3.2.5. Microneedling

6.4. Global Acne Scar Treatment Market Attractiveness Analysis, by Product

7. Global Acne Scar Treatment Market Analysis and Forecast, by End-user

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Acne Scar Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

7.3.1. Hospitals

7.3.2. Clinics

7.3.3. Retail Pharmacies/E-commerce

7.4. Global Acne Scar Treatment Market Attractiveness Analysis, by End-user

8. Global Acne Scar Treatment Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Acne Scar Treatment Market Value (US$ Bn) Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Acne Scar Treatment Market Attractiveness Analysis, by Region

9. North America Acne Scar Treatment Market Analysis and Forecast

9.1.  Introduction

9.1.1.  Key Findings

9.2. North America Acne Scar Treatment Market Value (US$ Bn) Forecast, by Product, 2017–2031

9.2.1. Topical Medications

9.2.1.1. Alpha Hydroxyacids (AHAs)

9.2.1.2. Retinoids

9.2.1.3. Salicylic Acid

9.2.1.4. Others

9.2.2. In-office Procedures

9.2.2.1. Dermabrasion

9.2.2.2. Chemical Peels

9.2.2.3. Laser Resurfacing

9.2.2.4. Fillers

9.2.2.5. Microneedling

9.3. North America Acne Scar Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

9.3.1. Hospitals

9.3.2. Clinics

9.3.3. Retail Pharmacies/E-commerce

9.4. North America Acne Scar Treatment Market Value (US$ Bn) Forecast, by Country, 2017–2031

9.4.1. U.S.

9.4.2. Canada

9.5. North America Acne Scar Treatment Market Attractiveness Analysis

9.5.1. By Product

9.5.2. By End-user

9.5.3. By Country

10. Europe Acne Scar Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1.  Key Findings

10.2. Europe Acne Scar Treatment Market Value (US$ Bn) Forecast, by Product, 2017–2031

10.2.1.  Topical Medications

10.2.1.1. Alpha Hydroxyacids (AHAs)

10.2.1.2. Retinoids

10.2.1.3. Salicylic Acid

10.2.1.4. Others

10.2.2. In-office Procedures

10.2.2.1. Dermabrasion

10.2.2.2. Chemical Peels

10.2.2.3. Laser Resurfacing

10.2.2.4. Fillers

10.2.2.5. Microneedling

10.3. Europe Acne Scar Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

10.3.1. Hospitals

10.3.2. Clinics

10.3.3. Retail Pharmacies/E-commerce

10.4. Europe Acne Scar Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Acne Scar Treatment Market Attractiveness Analysis

10.5.1. By Product

10.5.2. By End-user

10.5.3. By Country/Sub-region

11. Asia Pacific Acne Scar Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1.  Key Findings

11.2. Asia Pacific Acne Scar Treatment Market Value (US$ Bn) Forecast, by Product, 2017–2031

11.2.1. Topical Medications

11.2.1.1. Alpha Hydroxyacids (AHAs)

11.2.1.2. Retinoids

11.2.1.3. Salicylic Acid

11.2.1.4. Others

11.2.2. In-office Procedures

11.2.2.1. Dermabrasion

11.2.2.2. Chemical Peels

11.2.2.3. Laser Resurfacing

11.2.2.4. Fillers

11.2.2.5. Microneedling

11.3. Asia Pacific Acne Scar Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

11.3.1. Hospitals

11.3.2. Clinics

11.3.3. Retail Pharmacies/E-commerce

11.4. Asia Pacific Acne Scar Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Acne Scar Treatment Market Attractiveness Analysis

11.5.1. By Product

11.5.2. By End-user

11.5.3. By Country/Sub-region

12. Latin America Acne Scar Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1.  Key Findings

12.2. Latin America Acne Scar Treatment Market Value (US$ Bn) Forecast, by Product, 2017–2031

12.2.1. Topical Medications

12.2.1.1. Alpha Hydroxyacids (AHAs)

12.2.1.2. Retinoids

12.2.1.3. Salicylic Acid

12.2.1.4. Others

12.2.2. In-office Procedures

12.2.2.1. Dermabrasion

12.2.2.2. Chemical Peels

12.2.2.3. Laser Resurfacing

12.2.2.4. Fillers

12.2.2.5. Microneedling

12.3. Latin America Acne Scar Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

12.3.1. Hospitals

12.3.2. Clinics

12.3.3. Retail Pharmacies/E-commerce

12.4. Latin America Acne Scar Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Acne Scar Treatment Market Attractiveness Analysis

12.5.1. By Product

12.5.2. By Therapy

12.5.3. By End-user

12.5.4. By Country/Sub-region

13. Middle East & Africa Acne Scar Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1.  Key Findings

13.2. Middle East & Africa Acne Scar Treatment Market Value (US$ Bn) Forecast, by Product, 2017–2031

13.2.1. Topical Medications

13.2.1.1. Alpha Hydroxyacids (AHAs)

13.2.1.2. Retinoids

13.2.1.3. Salicylic Acid

13.2.1.4. Others

13.2.2. In-office Procedures

13.2.2.1. Dermabrasion

13.2.2.2. Chemical Peels

13.2.2.3. Laser Resurfacing

13.2.2.4. Fillers

13.2.2.5. Microneedling

13.3. Middle East & Africa Acne Scar Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

13.3.1. Hospitals

13.3.2. Clinics

13.3.3. Retail Pharmacies/E-commerce

13.4. Middle East & Africa Acne Scar Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Acne Scar Treatment Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By End-user

13.5.3. By Country/Sub-region

14. Competitive Landscape

14.1. Market Player – Competition Matrix (by tier and size of companies)

14.2.  Company Profiles

14.2.1. Merz Pharma GmbH & Co. KGaA

14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.1.2. Financial Overview

14.2.1.3. Product Portfolio

14.2.1.4. Strategic Overview

14.2.1.5. SWOT Analysis

14.2.2. Bausch Health Companies, Inc.

14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.2.2. Financial Overview

14.2.2.3. Product Portfolio

14.2.2.4. Strategic Overview

14.2.2.5. SWOT Analysis

14.2.3. Sonoma Pharmaceuticals, Inc.

14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.3.2. Financial Overview

14.2.3.3. Product Portfolio

14.2.3.4. Strategic Overview

14.2.3.5. SWOT Analysis

14.2.4. Enaltus, LLC

14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.4.2. Financial Overview

14.2.4.3. Product Portfolio

14.2.4.4. Strategic Overview

14.2.4.5. SWOT Analysis

14.2.5. Revitol Corporation, Inc.

14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.5.2. Product Portfolio

14.2.5.3. Strategic Overview

14.2.5.4. SWOT Analysis

14.2.6. Scarguard Labs LLC

14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.6.2. Financial Overview

14.2.6.3. Product Portfolio

14.2.6.4. Strategic Overview

14.2.6.5. SWOT Analysis

14.2.7. CCA Industries, Inc.

14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.7.2. Financial Overview

14.2.7.3. Product Portfolio

14.2.7.4. Strategic Overview

14.2.7.5. SWOT Analysis

14.2.8. Johnson & Johnson

14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.8.2. Financial Overview

14.2.8.3. Product Portfolio

14.2.8.4. Strategic Overview

14.2.8.5. SWOT Analysis

14.2.9. Smith & Nephew plc

14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.9.2. Financial Overview

14.2.9.3. Product Portfolio

14.2.9.4. Strategic Overview

14.2.9.5. SWOT Analysis

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111596/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button